Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis.
The pathological and physiological roles of IL-6 amplifier activation.
Decrease of mutual information in brain electrical activity of patients with relapsing-remitting multiple sclerosis.
Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis.
Microenvironmental Regulation of Oligodendrocyte Replacement and Remyelination in Spinal Cord Injury.
Anti-Inflammatory Potential of Newly Synthesized 4-[(Butylsulfinyl)methyl]-1,2-benzenediol in Lipopolysaccharide-Stimulated BV2 Microglia.
Dimethyl fumarate for treating relapsing multiple sclerosis.
Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
Piroxicam confer neuroprotection in Cerebral Ischemia by inhibiting Cyclooxygenases, Acid- Sensing Ion Channel-1a and Aquaporin-4: an in silico comparison with Aspirin and Nimesulide.
miFRame: analysis and visualization of miRNA sequencing data in neurological disorders.
Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter.
Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach.
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
A case of neuromyelitis optica harboring both anti-aquaporin-4 antibodies and a pathogenic mitochondrial DNA mutation for Leber's hereditary optic neuropathy.
Neurodegeneration: From Multiple Sclerosis to Alzheimer's Disease.
Fulminant inflammatory demyelination: long-term course and magnetic resonance imaging findings.
Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern.
[Alemtuzumab is a new drug based on monoclonal antibodies for treatment multiple sclerosis: treatment possibilities and risks(review)].
Neuronal Hemoglobin Expression and Its Relevance to Multiple Sclerosis Neuropathology.
Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years.
Ocular Toxicities of MEK inhibitors and other targeted therapies.

Pages